Trial intelligence / Profile preview

Yunnan Baiyao for Distal Radius Fracture Pain

NCT05765747Unknown

Sponsor
Peking University Third Hospital
Start
Apr 2023
Primary completion
Dec 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of Yunnan Baiyao in distal radius fracture (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Visual Analog Scale at 14 weeks. Status: unknown.

02

Drugs

Yunnan Baiyao
03

Conditions

distal radius fracture

Beyond the preview

Go deeper on NCT05765747.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05765747.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call